Researchers Find A New Way To Target Neuroblastoma | CCI
Targeting mesothelin receptors with drug-loaded bacterial nanocells suppresses human mesothelioma tumour growth in mouse xenograft models | PLOS ONE
Targeting mesothelin receptors with drug-loaded bacterial nanocells suppresses human mesothelioma tumour growth in mouse xenograft models | PLOS ONE
EnGeneIC initiates Phase I trial of nanocellular anti-Covid-19 vaccine
The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infection | SpringerLink
Frontiers | Nanocell COVID-19 vaccine triggers a novel immune response pathway producing high-affinity antibodies which neutralize all variants of concern
Cyto-Immuno-Therapy for Cancer: A Pathway Elicited by Tumor-Targeted, Cytotoxic Drug-Packaged Bacterially Derived Nanocells
Cyto-Immuno-Therapy for Cancer: A Pathway Elicited by Tumor-Targeted, Cytotoxic Drug-Packaged Bacterially Derived Nanocells - ScienceDirect
EnGeneIC Announces Publication in Cancer Cell of a Scientific Paper Highlighting the Ability of EDV™ Nanocells to Mount Dual Assault on Cancer Cells
Schematic representation showing the mechanism of Anti-MSLN-BsAb EDV... | Download Scientific Diagram
Twitter-এ Drug Discovery News: ".@EnGeneIC #nanocells effectively deliver #cytotoxic payload + stimulating #immune responses to #cancers Mouse #models show how EDVs activate Th1 #cytokine response & CD8+ #Tcells for prolonged #tumor #remission
Targeting mesothelin receptors with drug-loaded bacterial nanocells suppresses human mesothelioma tumour growth in mouse xenograft models | PLOS ONE
Nanocell COVID-19 vaccine elicits potent neutralizing response
GBM Brain Cancer Therapy Wins FDA Orphan Drug Designation
Polymers | Free Full-Text | Advances on Non-Genetic Cell Membrane Engineering for Biomedical Applications
Frontiers | Nanocell COVID-19 vaccine triggers a novel immune response pathway producing high-affinity antibodies which neutralize all variants of concern
Bacteria and bacterial derivatives as drug carriers for cancer therapy - ScienceDirect
EnGeneIC publishes the COVID-EDV vaccine's novel mechanism
EnGeneIC Announces Publication in Cancer Cell of a Scientific Paper Highlighting the Ability of EDV™ Nanocells to Mount Dual Assault on Cancer Cells
Frontiers | Targeting EGFR in Esophagogastric Cancer
Cyto-Immuno-Therapy for Cancer: A Pathway Elicited by Tumor-Targeted, Cytotoxic Drug-Packaged Bacterially Derived Nanocells - ScienceDirect
Polymers | Free Full-Text | Advances on Non-Genetic Cell Membrane Engineering for Biomedical Applications
